<button id="hmfyl"><acronym id="hmfyl"></acronym></button>
    <button id="hmfyl"><acronym id="hmfyl"></acronym></button>
    <dd id="hmfyl"><noscript id="hmfyl"></noscript></dd>
      內網

      檢測到您當前使用瀏覽器版本過于老舊,會導致無法正常瀏覽網站;請您使用電腦里的其他瀏覽器如:360、QQ、搜狗瀏覽器的極速模式瀏覽,或者使用谷歌、火狐等瀏覽器。

      下載Firefox

      ENDOGENOUS CANNABINOIDS AND THE PURSUIT OF REWARD

      日期: 2019-05-14
      生命科學學院2019年度春季學期學術系列講座之十一
      題目:ENDOGENOUS CANNABINOIDS AND THE PURSUIT OF REWARD
      演講人:Joseph F. Cheer, Ph.D.
      Professor of Anatomy
      & Neurobiology and Psychiatry
      University of Maryland School of Medicine
      時間:2019年5月31日(星期五),13:00-14:30
      地點:金光生命科學大樓鄧祐才報告廳
      聯系人:挑戰班本科生張楚珩,1500012198@pku.edu.cn
      摘要:
      In the early stages of substance abuse, subjects receive a drug that is highly reinforcing and are thus likely to repeat the actions that led them to obtain it.  This is termed positive reinforcement. However, in a minority of people who develop an addiction phenotype, negative reinforcement also causes a behavior to be repeated, but in this case, the action causes a bad feeling or situation to go away. The mesolimbic dopamine system, which is thought to generate a teaching signal, is involved in the selection of advantageous behavioral repertoires. This brain pathway is under control of endocannabinoid (eCBs), ubiquitous signaling molecules that bind to the same receptor targeted by marijuana (CB1) known to strengthen responses leading to the procurement of reward. Here, we investigate how eCBs modulate dopaminergic encoding of cues predicting either, appetitive stimuli, the avoidance of punishment or aversive outcomes. We find that disrupting eCB signaling by treating animals with a CB1 receptor antagonist dose-dependently decreased concentrations of dopamine release in the nucleus accumbens that were time-locked to a warning signal that predicts avoidance of punishment while simultaneously weakening shock avoidance behavior, effectively shifting the behavioral outcome from avoidance to escape. We further demonstrate, using directed mutagenesis approaches, that 2AG release from dopamine neurons in the midbrain is a canonical mechanism responsible for the pursuit of rewards. Together these data suggest that eCBs might modify distinct behavioral responses related to aversive stimuli by modulating conditioned mesolimbic dopamine release events.  These findings suggest that therapies aimed at modifying tissue levels of eCBs may be used to prevent drug seeking driven by negative affective states.
      歡迎各位老師同學積極參加!
      中文字幕无码AⅤ免费